ClinicalTrialsFinder

Leukemia, Lymphocytic, Chronic, B-Cell Clinical Trials in Dallas, Texas

1 recruitingDallas, Texas

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Small Lymphocytic
Juno Therapeutics, a Subsidiary of Celgene320 enrolled86 locationsNCT03331198